USREV: Virology

For information contact

2016 USERV students for Virology.
2016 USERV students for Virology.

Application Dates

Nov 15 2016 App opens
February 1 Priority deadline
March 1 App closes
April 1 Decisions complete

Program Dates

June 4 2017 Arrival day
June 5 Program begins
August 9 Program ends
August 10 Departure day

Who should apply

Related fields

  • Biology
  • Biochemistry
  • Microbiology
  • Molecular Biology

This program gives preference to and encourages applications from students whose primary interest is exploring a career in biomedical research.


Participation in the Nebraska Summer Research Program is limited to students who meet the following criteria:
  • U.S. Citizen or Permanent Resident
  • Current undergraduate with at least one semester of coursework remaining before obtaining a bachelor's degree

See Eligibility for more information.

How to apply

Follow the application steps to submit the following materials.

About the Program

Join faculty finding solutions to diseases of epidemic proportions including HIV/AIDS, Herpesvirus, Human Papilloma Virus, Influenza and Chlorellavirus Biology


  • Competitive stipend: $5,000
  • Suite-style room and meal plan
  • Travel expenses to and from Lincoln
  • Campus parking and/or bus pass
  • Full access to the Campus Recreation Center and campus library system
  • Wireless internet access

Learn more about academic and financial benefits.


  • Department seminars and presentations
  • Professional development workshops (e.g., applying to graduate school, taking the GRE)
  • Welcome picnic
  • Day trip to Omaha's Henry Doorly Zoo
  • Canoe and camping trip
  • Research symposium

Mentors and Projects

Dr. Peter Angeletti Biological Sciences

Replication and encapsidation of human papillomaviruses.

Dr. Deborah M. Brown Biological Sciences

Innate immune response to influenza infections; generation and regulation of cytolytic CD 4 T cells.

Dr. Hernan Garcia-Ruiz Plant Pathology

Plant-Virus interactions:  Genetic analysis and mechanism of antiviral RNA silencing.

Dr. Qingsheng Li Biological Sciences

Investigation of HIV-1 mucosal transmission and its prevention using rhesus macaque, humanized mouse and HIV patients.

Dr. Fernando Osorio Veterinary and Biomedical Sciences

Swine virology: studies on viral pathogenesis, immunology and vaccinology which are centered on the pig. Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).

Dr. Asit Pattnaik Veterinary and Biomedical Sciences

Replication and assembly of RNA viruses.

Dr. James Van Etten Plant Pathology

The isolation and characterization of large dsDNA (encode >300 proteins) viruses that infect chlorella-like green algae.

Dr. Eric Weaver Biological Sciences

Vaccine antigen design and vaccine platform design

Our research program explores the use of bioinformatics, phylogenetics, immunology and molecular biology to study the basic mechanisms of host-pathogen interactions and to create improved vaccines against microbial diseases.  This research program can be broken into two arms, vaccine antigen design and vaccine platform design.  First, we are testing ancestral/centralized genes to determine if they are useful as universal vaccines in vivo.  In addition we are exploring systems biology approaches to improve vaccine antigen design to improve the breadth and efficacy of the vaccine antigens.  Second, vaccine platform design explores the use of alternative viral vectors as vaccines, as well as the development of safer more effective viral vaccine platforms.  

Dr. John West Nebraska Center for Virology

Developing synthetic immunity for anti-viral and anti-cancer treatment.

Dr. Matthew Wiebe Veterinary and Biomedical Sciences

Intrinsic intracellular immune defenses against viral DNA.

Dr. Charles Wood Biological Sciences

HIV and Kaposi's sarcoma herpes virus transmission and molecular biology.

Dr. Shi-Hua Xiang Veterinary & Biomedical Sciences

HIV vaccine design or OPPV-host interactions.

Dr. Luwen Zhang Biological Sciences

The herpesvirus-host interactions, the biology of the family of interferon regulatory factors, and the treatments for herpesvirus-triggered cancers.